- Off-Label Hirsutism Treatments.
Women troubled by hirsutism who find mechanical removal methods and local treatments ineffective have several systemic--though off-label--medical options, Dr. Anne Lucky said at the annual meeting of the American Academy of Dermatology. Hirsutism that is associated with hyperandrogenism often can ......
- Off-Label Hirsutism Treatments.
Women with hirsutism who find mechanical removal and local treatments ineffective have several off-label medical options, Dr. Anne Lucky said at the annual meeting of the American Academy of Dermatology in Washington, D.C. Hirsutism stemming from hyperandrogenism often can be ......
- Changes to tolcapone labeling allow less liver monitoring.
The Food and Drug Administration has approved new labeling that relaxes the liver enzyme monitoring recommendations for tolcapone, an adjunctive treatment for Parkinson's disease, according to the drug's manufacturer. The new label recommends monitoring serum glutamic-pyruvic transaminase (SGPT/ALT) and serum ......
- A tale of two conversations.
Patient "J," let's call her Jane, was in the ICU of her local hospital. She was seventy-five and suffering from end stage pulmonary disease, high blood pressure, and impending renal failure. She had an eighty-year-old husband and two children in ......
- Changes to tolcapone label ease liver monitoring advice.
The Food and Drug Administration has approved new labeling that relaxes the liver enzyme monitoring recommendations for tolcapone, an adjunctive treatment for Parkinson's disease, according to the drug's manufacturer. The new label recommends monitoring serum glutamic-pyruvic transaminase (SGPT/ALT) and serum ......
- Tolcapone's label changes relax liver enzyme monitoring advice.
The Food and Drug Administration has approved new labeling that relaxes the liver enzyme monitoring recommendations for tolcapone, an adjunctive treatment for Parkinson's disease, according to the drug's manufacturer. The new label recommends monitoring ALT and AST levels at baseline ......
- HIV entry inhibitors having trouble in trials.
SAN FRANCISCO -- Efforts to develop entry inhibitors, which constitute the first new class of anti-HIV drugs in years, have hit snags that could delay the entry of these novel agents into the pharmaceutical marketplace. The debut of entry inhibitors ......
- HIV entry inhibitors running into trouble in trials; one withdrawn.
SAN FRANCISCO -- Efforts to develop entry inhibitors, which constitute the first new class of anti-HIV drugs in years, have hit snags that could delay the entry of these novel agents into the pharmaceutical marketplace. The debut of entry inhibitors ......
- HIV entry inhibitors stuck in the pipeline.
SAN FRANCISCO -- Efforts to develop entry inhibitors, which constitute the first new class of anti-HIV drugs in years, have hit snags that could delay the entry of these novel agents into the pharmaceutical marketplace. The debut of entry inhibitors ......
- ARBIOS SYSTEMS ACQUIRES ASSETS FROM CIRCE BIOMEDICAL.
Arbios Systems, Inc., Los Angeles, Calif., (BB: ABOS), a biomedical device company with proprietary liver assist technologies useful in the diagnosis and treatment of acute liver failure, has acquired certain assets of Circe Biomedical, Inc. The acquired assets include, among ......
- Ireland orders withdrawal of nimesulide anti-arthritis drug.
The Irish Medicines Board (IMB) May 16 ordered the recall of an arthritis drug used by thousands of Irish patients after it was linked to liver failure in nine patients, three of whom have died, reported "The Irish Times." The ......
- FDA investigating kava kava. (Alternative Medicine).
Kava kava has been removed from pharmacy shelves in Germany and Switzerland after 24 reports of liver damage were attributed to the herbal supplement, Dr. Edzard Ernst said at a health care symposium sponsored by the University of Exeter (England)....
- Son's gift of life to dad.
Byline: Malathy Iyer MUMBAI: It's a story of father and son bonding, but with a slight difference. The role of a provider here was played by the 20-year-old son, Waseem, who was traumatised by the medical diagnosis that his 50-year-old ......
- Immunization key for patients on transplant list.
SEATTLE -- Liver transplant candidates, along with members of their households, should receive all recommended vaccines well before transplantation. It is important that transplant candidates are vaccinated early in the course of their disease because the response to many vaccines ......
- Liver failure may be the cause of jailed man's death, chief says.
Byline: LARRY BACON The Register-Guard FLORENCE - A man who died in a Florence jail cell had a history of acute alcoholism and possibly died of liver failure, Police Chief Lynn Lamm said Wednesday. Rick Leslie Lyman, 50, a transient ......